[体外成熟——多囊卵巢综合征的一种新的治疗选择]。

Gynakologisch-geburtshilfliche Rundschau Pub Date : 2008-01-01 Epub Date: 2008-01-17 DOI:10.1159/000111467

Michael von Wolff, Inge Eberhardt, Thomas Strowitzki

{"title":"[体外成熟——多囊卵巢综合征的一种新的治疗选择]。","authors":"Michael von Wolff, Inge Eberhardt, Thomas Strowitzki","doi":"10.1159/000111467","DOIUrl":null,"url":null,"abstract":"velopment of a new technique, called in vitro maturation (IVM), in which immature oozytes can be obtained without stimulation by exogenous gonadotropins, thereby avoiding the risk of an ovarian hyperstimulation syndrome. The introduction of IVM in Germany in 2005 has revealed a pregnancy rate in young patients of around 15% per treatment cycle. Even though the pregnancy rate is lower than in regular IVF treatments, its success rate is acceptable in PCOS patients as the risk of developing an ovarian hyperstimulation syndrome is avoided. IVM is therefore a new therapy that can be recommended in young PCOS patients. Copyright © 2008 S. Karger AG, Basel","PeriodicalId":12827,"journal":{"name":"Gynakologisch-geburtshilfliche Rundschau","volume":"48 1","pages":"24-30"},"PeriodicalIF":0.0000,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000111467","citationCount":"3","resultStr":"{\"title\":\"[In vitro maturation--a new therapeutic option in polycystic ovary syndrome].\",\"authors\":\"Michael von Wolff, Inge Eberhardt, Thomas Strowitzki\",\"doi\":\"10.1159/000111467\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"velopment of a new technique, called in vitro maturation (IVM), in which immature oozytes can be obtained without stimulation by exogenous gonadotropins, thereby avoiding the risk of an ovarian hyperstimulation syndrome. The introduction of IVM in Germany in 2005 has revealed a pregnancy rate in young patients of around 15% per treatment cycle. Even though the pregnancy rate is lower than in regular IVF treatments, its success rate is acceptable in PCOS patients as the risk of developing an ovarian hyperstimulation syndrome is avoided. IVM is therefore a new therapy that can be recommended in young PCOS patients. Copyright © 2008 S. Karger AG, Basel\",\"PeriodicalId\":12827,\"journal\":{\"name\":\"Gynakologisch-geburtshilfliche Rundschau\",\"volume\":\"48 1\",\"pages\":\"24-30\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000111467\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynakologisch-geburtshilfliche Rundschau\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000111467\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2008/1/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynakologisch-geburtshilfliche Rundschau","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000111467","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2008/1/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 3

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

[In vitro maturation--a new therapeutic option in polycystic ovary syndrome].

velopment of a new technique, called in vitro maturation (IVM), in which immature oozytes can be obtained without stimulation by exogenous gonadotropins, thereby avoiding the risk of an ovarian hyperstimulation syndrome. The introduction of IVM in Germany in 2005 has revealed a pregnancy rate in young patients of around 15% per treatment cycle. Even though the pregnancy rate is lower than in regular IVF treatments, its success rate is acceptable in PCOS patients as the risk of developing an ovarian hyperstimulation syndrome is avoided. IVM is therefore a new therapy that can be recommended in young PCOS patients. Copyright © 2008 S. Karger AG, Basel

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Gynakologisch-geburtshilfliche Rundschau

自引率

0.00%

发文量